A chemical compound that has had one or more of its atoms replaced by a radionuclide is known as a Radioactive Tracer, radiotracer, or radioactive label. Because of its radioactive decay, radioactive tracer compounds can be used to investigate the mechanism of chemical reactions by tracing the path that the radioisotope takes from reactants to products. Thus, the radioactive version of isotopic labelling is radiolabelling or radiotracing. The use of radioactive tracers is commonly referred to as radioisotope feeding experiments in biological contexts. It has been extensively used to follow the course of biological reactions to employ radioisotopes of hydrogen, carbon, phosphorus, sulfur, and iodine. A radioactive tracer can also be employed as a flow tracer or to monitor a substance's distribution inside a natural system like a cell or tissue. In the process of producing natural gas, radioactive tracers are also utilised to locate cracks caused by hydraulic fracturing. A number of imaging methods, including technetium scans, SPECT scans, and PET scans, are based on radioactive tracers. Carbon-14, an isotope that occurs naturally, is used in radiocarbon dating as an isotopic label.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia